Business Description
Chiome Bioscience Inc
NAICS : 325412
ISIN : JP3205350006
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.56 | |||||
Equity-to-Asset | 0.66 | |||||
Debt-to-Equity | 0.25 | |||||
Debt-to-EBITDA | -0.24 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.44 | |||||
Beneish M-Score | -3.29 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 0.9 | |||||
3-Year EBITDA Growth Rate | 12 | |||||
3-Year EPS without NRI Growth Rate | 11.9 | |||||
3-Year FCF Growth Rate | 17.1 | |||||
3-Year Book Growth Rate | -34.6 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 35.06 | |||||
9-Day RSI | 35.75 | |||||
14-Day RSI | 36.47 | |||||
6-1 Month Momentum % | 1.54 | |||||
12-1 Month Momentum % | -42.11 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.02 | |||||
Quick Ratio | 2.9 | |||||
Cash Ratio | 2.46 | |||||
Days Inventory | 84.1 | |||||
Days Sales Outstanding | 50.63 | |||||
Days Payable | 49.41 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -10 | |||||
Shareholder Yield % | -1.73 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 58.41 | |||||
Operating Margin % | -176.59 | |||||
Net Margin % | -178.77 | |||||
FCF Margin % | -156.67 | |||||
ROE % | -88.84 | |||||
ROA % | -64.27 | |||||
ROIC % | -261.73 | |||||
ROC (Joel Greenblatt) % | -469.67 | |||||
ROCE % | -84.96 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 8.92 | |||||
PB Ratio | 5.55 | |||||
Price-to-Tangible-Book | 5.55 | |||||
EV-to-EBIT | -4.67 | |||||
EV-to-EBITDA | -4.67 | |||||
EV-to-Revenue | 8.31 | |||||
EV-to-FCF | -5.3 | |||||
Price-to-Median-PS-Value | 0.33 | |||||
Price-to-Net-Current-Asset-Value | 6.2 | |||||
Price-to-Net-Cash | 8.78 | |||||
Earnings Yield (Greenblatt) % | -21.41 | |||||
FCF Yield % | -15.95 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Chiome Bioscience Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil 円) | 682.464 | ||
EPS (TTM) (円) | -24.62 | ||
Beta | 0.66 | ||
Volatility % | 32.93 | ||
14-Day RSI | 36.47 | ||
14-Day ATR (円) | 3.661946 | ||
20-Day SMA (円) | 125.65 | ||
12-1 Month Momentum % | -42.11 | ||
52-Week Range (円) | 117 - 233 | ||
Shares Outstanding (Mil) | 54.95 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Chiome Bioscience Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Chiome Bioscience Inc Stock Events
Event | Date | Price(円) | ||
---|---|---|---|---|
No Event Data |
Chiome Bioscience Inc Frequently Asked Questions
What is Chiome Bioscience Inc(TSE:4583)'s stock price today?
When is next earnings date of Chiome Bioscience Inc(TSE:4583)?
Does Chiome Bioscience Inc(TSE:4583) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |